E

When things fall apart

One of the things that struck me at this year’s ESMO conference was the sheer variety and richness…

September 29, 2021
E

COAST to coast – contemplating key Stage III trials in NSCLC

A deep dive into the phase 2 COAST study, along with some expert anecdotes

September 22, 2021
E

Spotting the path forward

Developmental Therapeutics is hard, how do companies go about finding a way forward?

September 20, 2021
E

No, no absolutely not!

A look at the controversial adagrasib data in mCRC at ESMO21

September 20, 2021
E

And the data at ESMO21 is…

A practice changing trial of note at ESMO21

September 19, 2021
E

Storm Clouds or Sunny Skies? What’s on the horizon for Early Stage IO Development Data at ESMO21

A hard look at some IO agents in early development at ESMO21

September 18, 2021
E

ESMO21 Highlights from Day 1

Key posters of interest at ESMO21

September 17, 2021
E

Gritting it out

What are Gritstone up to behind the scenes and where are they headed in the near-term?

July 20, 2021